|
|
||||||||


* Asthma and Allergic Diseases Center, Department of Internal Medicine, and
Department of Rheumatology, University of Virginia, Charlottesville, VA 22908; and
Department of Genomics and Information Sciences, Hoffmann-LaRoche, Nutley, NJ 07110
Although high dose exposure to inhaled cat allergen (Fel d 1) can cause a form of tolerance (modified Th2 response), the T cell mechanism for this phenomenon has not been studied. T cell responses to Fel d 1 were characterized in both allergic (IgEpos) and modified Th2 (IgEnegIgGpos) responders as well as serum Ab-negative controls (IgEnegIgGneg). Fel d 1 stimulated high levels of IL-10 in PBMC cultures from all individuals, with evidence of Th2 and Th1 cytokine skewing in allergic and control subjects, respectively. Using overlapping peptides, epitopes at the N terminus of Fel d 1 chain 2 were shown to stimulate strong T cell proliferation and to preferentially induce IL-10 (peptide 2:1 (P2:1)) or IFN-
(P2:2) regardless of the allergic status of the donor. Injection of cat extract during conventional immunotherapy stimulated expansion of IL-10- and IFN-
-producing chain 2 epitope-specific T cells along with increased Fel d 1-specific serum IgG and IgG4 Ab. Six of 12 modified responders expressed the major HLA-DRB1 allele, *0701, and both P2:1 and P2:2 were predicted ligands for this allele. Cultures from DR7-positive modified responders produced the highest levels of IL-10 to P2:1 in addition to other major and minor epitopes within chains 1 and 2. In the presence of anti-IL-10 mAb, both T cell proliferation and IFN-
production were enhanced in a Fel d 1- and epitope-specific manner. We conclude that IL-10-producing T cells specific for chain 2 epitopes are relevant to tolerance induction, and that DR7-restricted recognition of these epitopes favors a modified Th2 response.
This article has been cited by other articles:
![]() |
A. D'Ambrosio, M. Colucci, O. Pugliese, F. Quintieri, and M. Boirivant Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation J. Leukoc. Biol., September 1, 2008; 84(3): 661 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gerstmayr, N. Ilk, I. Schabussova, B. Jahn-Schmid, E. M. Egelseer, U. B. Sleytr, C. Ebner, and B. Bohle A Novel Approach to Specific Allergy Treatment: The Recombinant Allergen-S-Layer Fusion Protein rSbsC-Bet v 1 Matures Dendritic Cells That Prime Th0/Th1 and IL-10-Producing Regulatory T Cells J. Immunol., December 1, 2007; 179(11): 7270 - 7275. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.L. Seneviratne, A.P. Black, L. Jones, A.S. Bailey, and G.S. Ogg The role of skin-homing T cells in extrinsic atopic dermatitis QJM, January 1, 2007; 100(1): 19 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Macaubas, J. Wahlstrom, A. P. Galvao da Silva, T. G. Forsthuber, G. Sonderstrup, W. W. Kwok, R. H. DeKruyff, and D. T. Umetsu Allergen-Specific MHC Class II Tetramer+ Cells Are Detectable in Allergic, but Not in Nonallergic, Individuals. J. Immunol., April 15, 2006; 176(8): 5069 - 5077. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Riedl, E. M. Landaw, A. Saxon, and D. Diaz-Sanchez Initial High-Dose Nasal Allergen Exposure Prevents Allergic Sensitization to a Neoantigen J. Immunol., June 1, 2005; 174(11): 7440 - 7445. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Seppala, P. Hagglund, P. A Wurtzen, H. Ipsen, P. Thorsted, T. Lenhard, P. Roepstorff, and M. D. Spangfort Molecular Characterization of Major Cat Allergen Fel d 1: EXPRESSION OF HETERODIMER BY USE OF A BACULOVIRUS EXPRESSION SYSTEM J. Biol. Chem., February 4, 2005; 280(5): 3208 - 3216. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Woodfolk Allergy and Dermatophytes Clin. Microbiol. Rev., January 1, 2005; 18(1): 30 - 43. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |